Complications of shock wave lithotripsy

Mitra R. De Cógáin, Amy Krambeck

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Shockwave lithotripsy (SWL) was introduced to clinical urologic practice in the 1980s with Dornier's HM3 lithotripter and has become a common first-line treatment modality for urolithiasis (Chaussy et al., J Urol 127:417-20, 1982). Initial SWL results were promising, and since that time, SWL has become the most commonly performed treatment for renal and ureteral stones (Chaussy and Fuchs, J Urol 92:339-43, 1986; Pearle, J Urol 173:848-57, 2005). As SWL is a noninvasive therapeutic modality, it initially was perceived as harmless to the kidney and surrounding organs (Chaussy and Fuchs, J Urol 92:339-43, 1986). However, multiple studies since that early experience have suggested or demonstrated deleterious effects of the repetitive shock waves required for successful stone fragmentation. These include acute injury to the kidney and other adjacent structures including the pancreas, colon, liver, spleen, pleura, and large blood vessels (McAteer and Evan, Semin Nephrol 28:200-13, 2008). Although SWL is generally well tolerated, it is imperative for practicing clinicians to be aware of the potential complications of this procedure. Current SWL requires the appropriate selection of a limited number of parameters for each patient, including number of shocks delivered, shock rate, and power. However, safe application of SWL therapy must include appropriate patient selection with attention to comorbid medical conditions, stone location, size, and composition. Some complications may arise only in patients or stones that are inappropriately selected for SWL therapy. This chapter focuses on the possible complications of SWL, as well as techniques to optimize patient outcomes, while decreasing the risk for complications.

Original languageEnglish (US)
Title of host publicationSurgical Management of Urolithiasis: Percutaneous, Shockwave and Ureteroscopy
PublisherSpringer New York
Pages177-190
Number of pages14
Volume9781461469377
ISBN (Electronic)9781461469377
ISBN (Print)1461469368, 9781461469360
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Lithotripsy
Shock
Kidney
Therapeutics
Urolithiasis
Pleura
Acute Kidney Injury
Patient Selection
Blood Vessels
Pancreas
Colon
Spleen
Liver

ASJC Scopus subject areas

  • Medicine(all)

Cite this

De Cógáin, M. R., & Krambeck, A. (2013). Complications of shock wave lithotripsy. In Surgical Management of Urolithiasis: Percutaneous, Shockwave and Ureteroscopy (Vol. 9781461469377, pp. 177-190). Springer New York. https://doi.org/10.1007/978-1-4614-6937-7_14

Complications of shock wave lithotripsy. / De Cógáin, Mitra R.; Krambeck, Amy.

Surgical Management of Urolithiasis: Percutaneous, Shockwave and Ureteroscopy. Vol. 9781461469377 Springer New York, 2013. p. 177-190.

Research output: Chapter in Book/Report/Conference proceedingChapter

De Cógáin, MR & Krambeck, A 2013, Complications of shock wave lithotripsy. in Surgical Management of Urolithiasis: Percutaneous, Shockwave and Ureteroscopy. vol. 9781461469377, Springer New York, pp. 177-190. https://doi.org/10.1007/978-1-4614-6937-7_14
De Cógáin MR, Krambeck A. Complications of shock wave lithotripsy. In Surgical Management of Urolithiasis: Percutaneous, Shockwave and Ureteroscopy. Vol. 9781461469377. Springer New York. 2013. p. 177-190 https://doi.org/10.1007/978-1-4614-6937-7_14
De Cógáin, Mitra R. ; Krambeck, Amy. / Complications of shock wave lithotripsy. Surgical Management of Urolithiasis: Percutaneous, Shockwave and Ureteroscopy. Vol. 9781461469377 Springer New York, 2013. pp. 177-190
@inbook{9e2b746506574d61b351578761e3b8b3,
title = "Complications of shock wave lithotripsy",
abstract = "Shockwave lithotripsy (SWL) was introduced to clinical urologic practice in the 1980s with Dornier's HM3 lithotripter and has become a common first-line treatment modality for urolithiasis (Chaussy et al., J Urol 127:417-20, 1982). Initial SWL results were promising, and since that time, SWL has become the most commonly performed treatment for renal and ureteral stones (Chaussy and Fuchs, J Urol 92:339-43, 1986; Pearle, J Urol 173:848-57, 2005). As SWL is a noninvasive therapeutic modality, it initially was perceived as harmless to the kidney and surrounding organs (Chaussy and Fuchs, J Urol 92:339-43, 1986). However, multiple studies since that early experience have suggested or demonstrated deleterious effects of the repetitive shock waves required for successful stone fragmentation. These include acute injury to the kidney and other adjacent structures including the pancreas, colon, liver, spleen, pleura, and large blood vessels (McAteer and Evan, Semin Nephrol 28:200-13, 2008). Although SWL is generally well tolerated, it is imperative for practicing clinicians to be aware of the potential complications of this procedure. Current SWL requires the appropriate selection of a limited number of parameters for each patient, including number of shocks delivered, shock rate, and power. However, safe application of SWL therapy must include appropriate patient selection with attention to comorbid medical conditions, stone location, size, and composition. Some complications may arise only in patients or stones that are inappropriately selected for SWL therapy. This chapter focuses on the possible complications of SWL, as well as techniques to optimize patient outcomes, while decreasing the risk for complications.",
author = "{De C{\'o}g{\'a}in}, {Mitra R.} and Amy Krambeck",
year = "2013",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-6937-7_14",
language = "English (US)",
isbn = "1461469368",
volume = "9781461469377",
pages = "177--190",
booktitle = "Surgical Management of Urolithiasis: Percutaneous, Shockwave and Ureteroscopy",
publisher = "Springer New York",

}

TY - CHAP

T1 - Complications of shock wave lithotripsy

AU - De Cógáin, Mitra R.

AU - Krambeck, Amy

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Shockwave lithotripsy (SWL) was introduced to clinical urologic practice in the 1980s with Dornier's HM3 lithotripter and has become a common first-line treatment modality for urolithiasis (Chaussy et al., J Urol 127:417-20, 1982). Initial SWL results were promising, and since that time, SWL has become the most commonly performed treatment for renal and ureteral stones (Chaussy and Fuchs, J Urol 92:339-43, 1986; Pearle, J Urol 173:848-57, 2005). As SWL is a noninvasive therapeutic modality, it initially was perceived as harmless to the kidney and surrounding organs (Chaussy and Fuchs, J Urol 92:339-43, 1986). However, multiple studies since that early experience have suggested or demonstrated deleterious effects of the repetitive shock waves required for successful stone fragmentation. These include acute injury to the kidney and other adjacent structures including the pancreas, colon, liver, spleen, pleura, and large blood vessels (McAteer and Evan, Semin Nephrol 28:200-13, 2008). Although SWL is generally well tolerated, it is imperative for practicing clinicians to be aware of the potential complications of this procedure. Current SWL requires the appropriate selection of a limited number of parameters for each patient, including number of shocks delivered, shock rate, and power. However, safe application of SWL therapy must include appropriate patient selection with attention to comorbid medical conditions, stone location, size, and composition. Some complications may arise only in patients or stones that are inappropriately selected for SWL therapy. This chapter focuses on the possible complications of SWL, as well as techniques to optimize patient outcomes, while decreasing the risk for complications.

AB - Shockwave lithotripsy (SWL) was introduced to clinical urologic practice in the 1980s with Dornier's HM3 lithotripter and has become a common first-line treatment modality for urolithiasis (Chaussy et al., J Urol 127:417-20, 1982). Initial SWL results were promising, and since that time, SWL has become the most commonly performed treatment for renal and ureteral stones (Chaussy and Fuchs, J Urol 92:339-43, 1986; Pearle, J Urol 173:848-57, 2005). As SWL is a noninvasive therapeutic modality, it initially was perceived as harmless to the kidney and surrounding organs (Chaussy and Fuchs, J Urol 92:339-43, 1986). However, multiple studies since that early experience have suggested or demonstrated deleterious effects of the repetitive shock waves required for successful stone fragmentation. These include acute injury to the kidney and other adjacent structures including the pancreas, colon, liver, spleen, pleura, and large blood vessels (McAteer and Evan, Semin Nephrol 28:200-13, 2008). Although SWL is generally well tolerated, it is imperative for practicing clinicians to be aware of the potential complications of this procedure. Current SWL requires the appropriate selection of a limited number of parameters for each patient, including number of shocks delivered, shock rate, and power. However, safe application of SWL therapy must include appropriate patient selection with attention to comorbid medical conditions, stone location, size, and composition. Some complications may arise only in patients or stones that are inappropriately selected for SWL therapy. This chapter focuses on the possible complications of SWL, as well as techniques to optimize patient outcomes, while decreasing the risk for complications.

UR - http://www.scopus.com/inward/record.url?scp=84949175292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949175292&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-6937-7_14

DO - 10.1007/978-1-4614-6937-7_14

M3 - Chapter

AN - SCOPUS:84949175292

SN - 1461469368

SN - 9781461469360

VL - 9781461469377

SP - 177

EP - 190

BT - Surgical Management of Urolithiasis: Percutaneous, Shockwave and Ureteroscopy

PB - Springer New York

ER -